Malarone Paediatric Tablet is a child-friendly antimalarial medication containing Atovaquone 62.5 mg and Proguanil Hydrochloride 25 mg per tablet. It is used both for the treatment of uncomplicated malaria and the prevention (prophylaxis) of malaria in children, especially in regions where Plasmodium falciparum is resistant to other antimalarials.

Atovaquone works by inhibiting parasite energy production, while Proguanil disrupts parasite DNA synthesis. Together, they provide a powerful dual action that both treats existing infections and prevents new ones. The paediatric formulation ensures lower, weight-based dosing suitable for children.

Key Benefits:

• Dual Action Formula: Atovaquone 62.5 mg + Proguanil 25 mg for strong malaria protection.
• For Treatment and Prevention: Effective in both clearing malaria and preventing infection.
• Child-Friendly Dose: Designed specifically for children, with dosing based on weight.
• Trusted Worldwide: Recommended in regions with drug-resistant malaria.

How to Use:

Give the tablets exactly as prescribed by your healthcare provider.

• For treatment: Usually once daily for 3 consecutive days, with food or a milky drink.
• For prevention: Start 1–2 days before entering a malaria area, continue daily during the stay, and for 7 days after leaving. Always follow the weight-based dosing chart provided by the healthcare professional.